NCT01999101View on ClinicalTrials.gov

Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2016

Conditions
Non Alcoholic Fatty Liver Disease
Interventions
DRUG

Px-104

28 days treatment

Trial Locations (1)

1090

Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Vienna

Sponsors
All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

lead

Phenex Pharmaceuticals AG

INDUSTRY